ArticleCancers2023

Concurrent Inhibition of Akt and ERK Using TIC-10 Can Overcome Venetoclax Resistance in Mantle Cell Lymphoma.

Agnete Marie Granau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.